Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Unger

Showing results (71-80 of 9,203) with videos related to

Pageof 921
Sort By:
Fortschritte Der Medizin|December 20, 1988
[Salt and hypertension: results of the Intersalt study]T Unger
Fortschritte Der Medizin|April 30, 1990
[Producing a "defense reaction" by substance P. Can neuropeptides contribute to the development of hypertension?]T Unger
The Journal of Nursing Administration|July 1, 1985
Building a classification system that worksJ Unger
Fortschritte Der Medizin|August 30, 1997
[Differential therapy of hypertension becomes more specific. Interview by Dr. R.-G. Sommer]T Unger
Fortschritte Der Medizin|January 7, 1998
[Antihypertensive therapy: the end of the flag pole?]T Unger
The Journal of Family Practice|June 19, 2018
A Clinical Overview of Once-weekly Glucagon-like Peptide-1 Receptor AgonistsJeff Unger
Hospital Financial Management|February 10, 1982
Federal employees' health insurance: largest competitive health program faces a crisisW Unger
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 14, 1999
Regarding the death of density debateW Unger
Osterreichische Krankenpflegezeitschrift|May 2, 2000
[Use of a nursing model in the operating room--a study]D Unger
Blood Pressure. Supplement|November 4, 2000
Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetilT Unger
Pageof 921

Showing results (71-80 of 9,203) with videos related to

Sort By:
Pageof 921
Fortschritte Der Medizin|December 20, 1988
[Salt and hypertension: results of the Intersalt study]T Unger
Fortschritte Der Medizin|April 30, 1990
[Producing a "defense reaction" by substance P. Can neuropeptides contribute to the development of hypertension?]T Unger
The Journal of Nursing Administration|July 1, 1985
Building a classification system that worksJ Unger
Fortschritte Der Medizin|August 30, 1997
[Differential therapy of hypertension becomes more specific. Interview by Dr. R.-G. Sommer]T Unger
Fortschritte Der Medizin|January 7, 1998
[Antihypertensive therapy: the end of the flag pole?]T Unger
The Journal of Family Practice|June 19, 2018
A Clinical Overview of Once-weekly Glucagon-like Peptide-1 Receptor AgonistsJeff Unger
Hospital Financial Management|February 10, 1982
Federal employees' health insurance: largest competitive health program faces a crisisW Unger
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 14, 1999
Regarding the death of density debateW Unger
Osterreichische Krankenpflegezeitschrift|May 2, 2000
[Use of a nursing model in the operating room--a study]D Unger
Blood Pressure. Supplement|November 4, 2000
Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetilT Unger
Pageof 921